Universe Pharmaceuticals INC 20-F for FY2025
Universe Pharmaceuticals INC (UPC)
20-F
2026-01-29
For: 2025-09-30
View Original
Added on
April 09, 2026
About this 20-F
Universe Pharmaceuticals INC filed this 20-F on January 29, 2026, covering the fiscal year ended September 30, 2025 (FY2025).
Headline figures
Fiscal year ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $17.86B
- down 22.4% from $23.02B a year earlier
- Net loss
- $3.67B
- compared with a net loss of $8.73B a year earlier
- Diluted EPS
- -$8.06
- compared with -$626.96 a year earlier